See how top analysts and institutions rate JNJ — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Daiwa Securities | Upgrade | Neutral → Outperform | $203 | 2025-10-20 |
| Wells Fargo | Upgrade | Equal Weight → Overweight | $212 | 2025-10-03 |
| Guggenheim | Upgrade | Neutral → Buy | $206 | 2025-09-23 |
| Erste Group | Upgrade | Hold → Buy | 2025-07-23 | |
| Leerink Partners | Downgrade | Outperform → Market Perform | $153 | 2025-05-13 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 3 | 9 | 11 | 0 | 1 |
| October 2025 | 3 | 9 | 11 | 0 | 1 |
| September 2025 | 2 | 9 | 13 | 0 | 0 |
| August 2025 | 2 | 8 | 14 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for JNJ, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
